Impact of Imiglucerase Supply Shortage on Clinical and Laboratory Parameters in Norrbottnian Patients with Gaucher Disease Type 3

A viral contamination of the production plant producing imiglucerase (Cerezyme™) resulted in an unpredicted worldwide shortage of global supplies during 2009–2010. The aim of the study was to describe the effects of dose reduction of enzyme replacement therapy (ERT) in adults with Norrbottnian form...

Descripción completa

Detalles Bibliográficos
Autores principales: Machaczka, Maciej, Kämpe Björkvall, Cecilia, Wieremiejczyk, Joanna, Paucar Arce, Martin, Myhr-Eriksson, Kristina, Klimkowska, Monika, Hägglund, Hans, Svenningsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Basel 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289531/
https://www.ncbi.nlm.nih.gov/pubmed/25205209
http://dx.doi.org/10.1007/s00005-014-0308-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289531/
https://www.ncbi.nlm.nih.gov/pubmed/25205209
http://dx.doi.org/10.1007/s00005-014-0308-8

Ejemplares similares